Back to search results

Rutgers University Study of Breast Cancer Genetics

This study from Rutgers University is looking for 25,000 people to help understand how genes affect breast cancer risk. You can join if you are 18 or older, live in the U.S., and can follow instructions in English online. You don't need to have had cancer to participate. The study involves providing a saliva sample (for DNA) and answering health surveys online. Researchers will look for genetic risk variants (changes in genes that might increase risk) linked to breast cancer over two years. The goal is to improve our understanding of breast cancer's genetic causes, which can help with developing new treatments. As a thank you, you can choose to receive information about your genetic ancestry for free.

Study design
This is an observational study aiming to enroll 25,000 participants. It is not specified if it is randomized or blinded.
What's involved
You will complete health surveys online and provide a saliva sample using a kit mailed to your home. This takes about 20 minutes.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, genetic risk variants, will be measured at 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06773897

Rutgers University Study of the Genetics of Breast Cancer.

Recruiting
Not specifiedAges 18+Observational
Rutgers, The State University of New Jersey
~25,000 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:Saliva sampleHealth Surveys

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Genetic risk variants associated with breast cancer
Measured over 2 years

Conditions

Breast Cancer Risk
Breast Cancer Prevention
Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
New Jersey1

Study leadership

  • Tara Matise, Ph.D. · PRINCIPAL_INVESTIGATOR · Rutgers, The State University of New Jersey

Who to contact

Tara Matise, Ph.D.
[email protected]
848-445-3125
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

age 18 years or older
currently living in the United States
able to understand and follow written instructions in English
have access to the internet and a computer, laptop, tablet or smart phone
willing to provide written informed consent for participation
willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home
willing to complete a survey with questions about health related to the study of breast cancer.

What this trial measures

  • Genetic risk variants associated with breast cancer2 years

    Genetic factors will be measured through whole exome sequencing along with genotyping of common variants, and then correlated with breast cancer and breast cancer subtype.